CRBU
Caribou Biosciences, Inc. (CRBU)
NASDAQ · Healthcare
Caribou Biosciences, Inc. annual/quarterly shareholder equity history from 2020 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Caribou Biosciences, Inc. shareholder equity for the quarter ending December 31, 2025 were 122.2M, a 51.70% decrease year-over-year.
- Caribou Biosciences, Inc. shareholder equity for 2025 were 122.2M, a 51.70% decrease from 2024.
- Caribou Biosciences, Inc. shareholder equity for 2024 were 253.0M, a 31.34% decrease from 2023.
- Caribou Biosciences, Inc. shareholder equity for 2023 were 368.4M, a 22.44% increase from 2022.
- Caribou Biosciences, Inc. shareholder equity for 2022 were 300.9M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Caribou Biosciences, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $122 |
| 2024 | $253 |
| 2023 | $368 |
| 2022 | $301 |
| 2021 | $388 |
| 2020 | $-23 |
| Caribou Biosciences, Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $122 |
| 2024-12-31 | $253 |
| 2023-12-31 | $368 |
| 2022-12-31 | $301 |
| 2021-12-31 | $388 |
| 2020-12-31 | $-23 |
Caribou Biosciences, Inc. Shareholder Equity — FAQ
Caribou Biosciences, Inc. (CRBU) shareholder equity over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CRBU's shareholder equity history?
The chart and table above show Caribou Biosciences, Inc.'s shareholder equity by year and by quarter, including the growth rate.